EXPERIENCE
Doctor Evidence (DRE) is a software, data, and services company that has applied more than a decade of deep domain knowledge and the latest in applied artificial intelligence (AI) technology to offer clients the most robust and agile system to quickly find and analyze medical literature for their living evidence initiatives.
Doctor Evidence CEO Awarded Two Honorary Fellowships Robert Battista was recently selected for fellowship in the Royal College of Physicians of Edinburgh and the Royal Society for Public Health.
Doctor Evidence Conducted Systematic Evidence Review for Leading Cardiology Societies for Bradycardia Guideline Evidence Review and Analyses
SANTA MONICA, Calif., Nov. 6, 2018 /PRNewswire/ -- Today, the American College of Cardiology (ACC), American Heart Association (AHA), and Heart Rhythm Society (HRS) published guidelines on the diagnosis and treatment of bradycardia, an abnormally slow heart rate, along with the supporting systematic review. The 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay were simultaneously published in Circulation, the Journal of the American College of Cardiology (JACC), and HeartRhythm. An Executive Summary was also published in all three journals: Circulation, JACC, and HeartRhythm.
Connecting Published Data To Real World Evidence: What's The DIF (Data Impact Factor)
SANTA MONICA, Calif., Nov. 5, 2018 /PRNewswire/ -- Doctor Evidence has launched DIF—the Data Impact Factor—technology for identifying data cohorts, across time and various reported data sets. As technology progresses, it has become possible to move from past paradigms, like the Journal Impact Factor, which is an index of the relative influence of leading journals. Today's innovative technologies can assign actual weights, prominence, and influence factors to individual data cohorts across all research or within a selected topic area. DIF embraces the increased capabilities for micro-tagging of clinical trial research and subsequent representations of that data.
The American Society Of Hematology To Make Its Meeting Abstracts Available In Leading Artificial Intelligence Technology Platform
WASHINGTON, Oct. 26, 2018 /PRNewswire/ -- The American Society of Hematology (ASH), has entered into an agreement with Doctor Evidence (DRE) to host ASH annual meeting abstracts in DRE's innovative DOC Search artificial intelligence technology platform. ASH is the world's largest professional society serving both clinicians and scientists around the world who are working to conquer blood diseases.
American Thoracic Society publishes guideline on malignant pleural effusions; Doctor Evidence collaborated on the underlying meta-analysis
New Guideline Recommends Minimally Invasive Ways of Treating Malignant Pleural Effusions
Oct. 1, 2018─A new guideline to help clinicians manage malignant pleural effusions (MPEs) has been developed by the American Thoracic Society, the Society of Thoracic Surgeons and the Society of Thoracic Radiology. The clinical practice guideline is published online in the Oct. 1 American Journal of Respiratory and Critical Care Medicine.
Services
- Rapid Assessment
- Systematic Literature
- Competitor Label
- Focused Literature
- Payer Dossier
- Clinical Analytics
- Network Meta-Analyses
- Economic Assessment
- Medical Writing
- Scientific Publications